Diffuse esophageal spasm medical therapy

Revision as of 14:37, 20 November 2017 by Madhu Sigdel (talk | contribs)
Jump to navigation Jump to search

Diffuse esophageal spasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diffuse esophageal spasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Diffuse esophageal spasm medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse esophageal spasm medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse esophageal spasm medical therapy

CDC on Diffuse esophageal spasm medical therapy

Diffuse esophageal spasm medical therapy in the news

Blogs on Diffuse esophageal spasm medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Diffuse esophageal spasm medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]

Overview

The mainstay of treatment for DES is medical therapy with calcium channel blockers, and/or tricyclic antidepressants.

Medical Therapy

  • Patients with are treated with calcium channel blockers if dysphagia is predominant , whereas patients with predominant chest pain are treated with either calcium channel blockers or tricyclic antidepressants.
  • Nitrate releasing drugs and local injection of botox toxin are used if above measures fail.
  • Proton pump inhibitors are used in secondary DES.

Diffuse esophageal spasm

  • 1 Primary DES
    • 1.1 Adult
      • Preferred regimen (1): diltiazem 180-240 mg PO q24h for 7-10 days. (Contraindications: Hypersensitivity, AV block (2nd or 3rd degree), hypotension, acute MI)
      • Preferred regimen (2): imipramine 25-50 mg at bedtime for 14-21 days.
      • Alternative regimen (2):Isosorbide 10 mg or sildenafil 50 mg PO as needed.
    • 1.2 Pediatric
        • Preferred regimen (1): diltiazem 1.5-2mg/kg 50 mg/kg PO in 3-4 divided doses.
        • Preferred regimen (2): imipramine 10-25 mg PO per day at bedtime. (maximum, 50mg/day if 6 years to < 12 years and 75mg/day if = or > 12 years).
  • 2 Secondary DES (treatment of GERD)
    • 2.1 Adult
      • Preferred regimen (1): omeprazole 20mg PO q24h for 4 weeks
    • 2.2 Pediatric for =<1 year and >= 16yrs
      • Preferred regimen (1): 5kg to <10 kg; omeprazole 5mg PO q24h for 4 weeks
      • 10kg to ,20 kg; omeprazole 10mg PO q24h for 4 weeks
      • >= 20 kg; omeprazole 20mg PO q24h for 4 weeks.
  • Refractory cases
  • Cases refractory to above treatment,endoscopic injection of Botulinum toxin 100U is the next medical therapy.


References

Template:WH Template:WS